Skip to content

Effect of Extracorporeal Shock Wave in the Treatment of Knee Osteoarthritis

Effect of Extracorporeal Shock Wave in the Treatment of Knee Osteoarthritis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03962270
Enrollment
36
Registered
2019-05-24
Start date
2018-08-01
Completion date
2019-08-01
Last updated
2019-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cartilage Injury, Knee Osteoarthritis

Keywords

Extracorporeal Shock Wave Therapy, Knee Osteoarthritis, Cartilage Injury

Brief summary

In this study, the effectiveness of ESWT in the treatment of knee OA was investigated from the perspective of cartilage injury,and to prove that shockwave could delay the early and middle stage OA progression by improving cartilage condition

Interventions

DEVICEshock wave device

The experimental group (group ESWT) guided by ultrasound: conventional rehabilitation training is given priority to with strength training, application of pain when necessary, under the guidance of ultrasound ESWT treatment control group (routine rehabilitation group) : conventional rehabilitation training is given priority to with strength training, oral pain when necessary, under the guidance of ultrasound ESWT treatment (shock energy flow density of 0)

Sponsors

Peking University Third Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Knee joint ROM normal or near normal: flexion 110 ° or reach 0 ° or less * MR prompt exist cartilage damage, there is no lack of full-thickness cartilage * Kellgren - Lawrence (K - L) grade II - III grade * The international association of cartilage repair cartilage damage grading system (ICRS) class I - III * Informed consent and sign relevant documents * Follow doctor's instructions and follow up on time

Exclusion criteria

* Metabolic arthritis * Trauma of bone joint * Inflammatory diseases * Previous knee surgery history * History of knee cavity injection in the past 6 months * Serious cardiovascular diseases, pulmonary diseases or other serious diseases affecting survival, etc

Design outcomes

Primary

MeasureTime frameDescription
magnetic resonance imaging of kneeBaseline (before treatment)t2 mapping

Countries

China

Contacts

Primary Contactmouwang 谋望 zhou, master
zhoumouwang@163.com13910092892
Backup Contactmingzhen 明真 Lee, bachelor
mingzhenli@126.com18810334425

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026